High Potency Active Pharmaceutical Ingredient (HPAPI) Market to Become Worth US$25.11 bn by 2023
The booming oncology research and rising cases of cancer, diabetes, and other cardiovascular diseases have created a sizeable demand for dedicated treatments, thereby driving the high potency active pharmaceutical ingredient (HPAPI) market. The HPAPI market stood at a valuation of US$2.64 bn in 2014. The cost containment strategies adopted by companies through outsourcing are favoring market growth. This has brought down the cost of drugs drastically, making them affordable to a larger audience.
Obtain Report Details @ https://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html
The positive result of this trend is seen on the increased focus of companies on drug development and commercialization. As a result of these favorable trends, the HPAPI market is projected to be worth US$25.11 bn by 2023. Between 2015 and 2023, the market is expected to expand at a CAGR of 8.3%.
A promising pipeline of targeted therapeutic drugs will also help the market progress in the coming years. These drugs have minimal side effects and impact targeted areas, thereby helping the patient to recover faster with no lingering after effects. These positive perceptions surrounding HPAPIs combined with the near-expiration dates of blockbuster drugs, which will offer several generic drug manufacturers a chance to offer affordable drugs, will further the market’s growth. Consistent research and development to mimic branded drugs will create alternative and cost-effective treatments for patients across the globe, thereby augmenting the growth rate of the market.
Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=748
Emerging Nations in Asia Pacific Becoming Hubs of Generic Drug Manufacturing, to Aid HPAPI Market Growth
Asia Pacific is the expected to be the most lucrative market for high potency active pharmaceutical ingredients due to the soaring contract manufacturing activities in the region. Analysts predict that China will surpass Japan’s current share of 40% in the Asia Pacific market by the end of 2025. This change will be a result of low labor costs in China, well-equipped manufacturing plants, and supportive foreign exchange policies.
India will also be an upcoming high potency active pharmaceutical ingredients market due to the growing concentration of pharmaceutical manufacturing activities in the country. In the forecast period, the country is expected to be the hub for generic drug manufacturing. The growing investments by key players in India are also anticipated to boost this market in the near future. During the forecast period of 2015 to 2023, the Asia Pacific HPAPI market is expected to rise at a CAGR of 10.1%.
Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=748
Oncology Drugs Show Maximum Demand
The oncology drugs segment has been the leading segment of the global high potency active pharmaceutical ingredient market. This segment is expected to expand at CAGR of 8.3% during the forecast period. The introduction of innovative drugs is the primary growth driver for the oncology segment. Analysts predict that the patent expiry of blockbuster drugs such as Herceptin, Rituxan, and Humira will pave the way for generic drug manufacturers, thereby making these drugs affordable to a wide number of patients.
Some of the leading players operating in the global high potency active pharmaceutical ingredient market are WuXi AppTec, Sigma-Aldrich Co. LLC, Pfizer, Inc., Sandoz International GmbH, Novasep, Lonza Group, Dr. Reddy’s Laboratories, Cambrex Corporation, and Alkermes plc. The fragmented nature of this market will result in strategies to acquire and merge with regional players to gain the first-mover advantage.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High Potency Active Pharmaceutical Ingredient (HPAPI) Market to Become Worth US$25.11 bn by 2023 here
News-ID: 1846351 • Views: 105
More Releases from Transparency Market Research
Potential Impact of COVID-19 on Intelligent Virtual Assistant Market
Speech Recognition Software Preferred in Hospitals to Reduce Overheads amidst COVID-19 The South Asian Association for Regional Cooperation (SAARC) is deploying speech recognition support to clients who are keen on purchasing speech recognition software for commercial purposes. Speech recognition software are in high demand amidst the COVID-19 (coronavirus) pandemic in order to provide remote services to users in the realms of banking and financial services and the retail shopping sector. Thus, companies
Security Printing Market Security Printing Market
Security Printing Market: An Overview Increased cases of forgery and counterfeiting practices are anticipated to drive the security printing market over the forecast period. Counterfeiting practices are particularly prevalent in bank notes, passports, postage stamps, identity cards, stock certificates, and contraband. Security printing helps in prevention of tampering and forgery of the instruments mentioned above. Obtain Report Details @ https://www.transparencymarketresearch.com/security-printing-market.html The key end market verticals in security printing market includes Banking, Financial Services
Edible Packaging Market Facts and Forecast Predictions Presented Untill 2024
The demand within the global edible packaging market has been rising on account of the nascence and innovative appeal of this form of packaging, finds Transparency Market Research (TMR). The competitive dynamics of the global edible packaging market largely depend on advancements in the field of food packaging. Obtain Report Details @ https://www.transparencymarketresearch.com/edible-packaging-market.html The brilliance of a handful of market vendors in the global edible packaging market has given an edge to
Vacuum Packaging Market is expected to reach US$22.8 bn by the end of 2024
Augmented demand for packaged hygienic food is likely to escalate the demand for vacuum packaging solutions in the years to come. The global vacuum packaging market is likely to rise at 4.9% CAGR over the tenure of the forecast, from 2016 to 2024. Various benefits of vacuum packing such as product safety, extended shelf life, and hygiene are likely to foster the growth of the market. Obtain Report Details @ https://www.transparencymarketresearch.com/vacuum-packaging-market.html The
More Releases for HPAPI
High Potency Active Pharmaceutical Ingredients (HPAPI) Market Outlook To 2024
High Potency Active Pharmaceutical Ingredients (HPAPI) Market Outlook To 2024: Key Product Categories (Synthetic, Biotech), Type (Innovative, Generic), End-Use (Oncology, Hormonal, Glaucoma), Regional Segmentation, Competitive Dynamics, Pricing Analysis (OPP, IPP, RAP) And Segment Forecast The global high potency active pharmaceutical Ingredients (HPAPI) Market was valued at $14.36 billion in 2016 and is forecast to grow at a steady CAGR of 8.4% between 2017 and 2024, culminating in 2024 global revenue of
Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Researc …
This report studies the global High Performance Active Pharmaceutical Ingredients (HPAPI) market status and forecast, categorizes the global High Performance Active Pharmaceutical Ingredients (HPAPI) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bristol-Myers Squibb Novartis Sanofi Aventis Pfizer Lonza Novasep Hospira
HPAPI 2019 Conference: Exclusive Interview Released with AstraZeneca
Peter Marshall from AstraZeneca will be speaking at SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference which will take place in London on 13th-14th May. He will be discussing the latest developments in the industry with a specific focus on the principles of pharmaceutical containment in isolator design. Ahead of the conference, SMi had interviewed him where he gave a taster of what he will be discussing. Peter said: “The
The Latest Techniques in HPAPI Facility Design
Amongst the myriad of potential pitfalls for the Highly Potential Active Pharmaceutical Ingredients (HPAPI) industry there is a requirement for all parties involved to have a blueprint in place to ensure all containment procedures are followed correctly. Yet, there is also a need to ensure that operations are maintained at the highest standards. At SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients Conference these issues will be discussed along with
HPAPI (High Potency Active Pharmaceutical Ingredients) Market Report 2018: Segme …
Global HPAPI (High Potency Active Pharmaceutical Ingredients) market research report provides company profile for Lonza, Novasep, Thermofisher Scientific, Alkermes, Cambrex, Dishman, Dr. Reddy’S and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report
SMi’s HPAPI 2018 Conference: Exclusive Interview Released with HPAPI Project S …
SMi are delighted to have our Chairman, Speaker and Workshop Host, Justin Mason-Home, Director, HPAPI Project Services Limited, onto the speaker panel for HPAPI 2018! About Justin: Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He has held senior positions and worked globally in potent biopharmaceutical occupational health and safety